Physician
General Surgery
Dr. Francesco M. Marincola, MD
|
|
Give Review
Francesco Marincola works in the field of General Surgery. He received awards:"Fellow (FACS)". Francesco Marincola is a published MD. He published 100 publications, including: 'Editorial overview: Tumour immunology: What's beyond today's success in tumor immunology.'
Publications
- Editorial overview: Tumour immunology: What's beyond today's success in tumor immunology.
- Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics.
- Type I cytokines synergize with oncogene inhibition to induce tumor growth arrest.
- Tumor-induced CD11b(+) Gr-1(+) myeloid-derived suppressor cells exacerbate immune-mediated hepatitis in mice in a CD40-dependent manner.
- Targeting proapoptotic protein BAD inhibits survival and self-renewal of cancer stem cells.
- The immune-related role of BRAF in melanoma.
- Differential Responses of Plasmacytoid Dendritic Cells to Influenza and Distinct Viral Pathogens.
- Direct T cell-tumour interaction triggers TH1 phenotype activation through the modification of the mesenchymal stromal cells transcriptional programme.
- Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers.
- Timing and intensity of exposure to Interferon-gamma critically determines the function of monocyte-derived dendritic cells.
- Non-BRAF-targeted therapy, immunotherapy, and combination therapy for melanoma.
- Corrigendum to "The modulation of hepatitis C virus 1a replication by PKR is dependent on NF-kB mediated interferon beta response in Huh7.5.1 cells" [Virology 438 (201...
- Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment.
- Longitudinal Study of Recurrent Metastatic Melanoma Cell Lines Underscores the Individuality of Cancer Biology.
- Towards the introduction of the Immunoscore in the classification of malignant tumors.
- CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2.
- Overexpression of HGF Promotes HBV-Induced Hepatocellular Carcinoma Progression and Is an Effective Indicator for Met-Targeting Therapy.
- IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes.
- BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis.
- Common pathways to tumor rejection.
- Molecular Signatures Associated with HCV-Induced Hepatocellular Carcinoma and Liver Metastasis.
- The international effort: building the bridge for Translational Medicine: Report of the 1st International Conference of Translational Medicine (ICTM).
- TNRC9 downregulates BRCA1 expression and promotes breast cancer aggressiveness.
- The modulation of hepatitis C virus 1a replication by PKR is dependent on NF-kB mediated interferon beta response in Huh7.5.1 cells.
- Investigation of residual hepatitis C virus in presumed recovered subjects.
- Quality Controls in Cellular Immunotherapies: Rapid Assessment of Clinical Grade Dendritic Cells by Gene Expression Profiling.
- A genetic inference on cancer immune responsiveness.
- Single-Cell Network Profiling of Peripheral Blood Mononuclear Cells from Healthy Donors Reveals Age- and Race-Associated Differences in Immune Signaling Pathway Activa...
- Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma.
- The Immune Score as a New Possible Approach for the Classification of Cancer.
- Defining the Critical Hurdles in Cancer Immunotherapy.
- Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cells.
- IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors.
- Molecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanoma.
- IFN-conditioned dendritic cells for the therapy of melanoma: what is missing?
- A human memory T cell subset with stem cell-like properties.
- Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes.
- Characterization of human melanoma cell lines and melanocytes by proteome analysis.
- gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma.
- Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens.
- Association of IFN-gamma signal transduction defects with impaired HLA class I antigen processing in melanoma cell lines.
- Linkage of microRNA and proteome-based profiling data sets: a perspective for the priorization of candidate biomarkers in renal cell carcinoma?
- Microarray analysis for a comprehensive immunological-status evaluation during cancer vaccine immune monitoring.
- RH genotyping in a sickle cell disease patient contributing to hematopoietic stem cell transplantation donor selection and management.
- Nucleophosmin is recognized by a cytotoxic T cell line derived from a rectal carcinoma patient.
- MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18.
- Immunotherapy for melanoma: current status and perspectives.
- Immunobiological characterization of cancer stem cells isolated from glioblastoma patients.
- MicroRNA expression differentiates histology and predicts survival of lung cancer.
- Genomic scale analysis of racial impact on response to IFN-alpha.
- Analysis of vaccine-induced T cells in humans with cancer.
- Targeted Therapy Database (TTD): a model to match patient's molecular profile with current knowledge on cancer biology.
- Enhanced antitumor activity induced by adoptive T-cell transfer and adjunctive use of the histone deacetylase inhibitor LAQ824.
- Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma.
- Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy.
- Evaluation of 3 clinical dendritic cell maturation protocols containing lipopolysaccharide and interferon-gamma.
- Increased effector-target cell conjugate formation due to HLA restricted specific antigen recognition.
- Bottom up: a modular view of immunology.
- Analysis of a high-throughput HLA antibody screening assay for use with platelet donors.
- Profiling of immune response to guide cancer diagnosis, prognosis, and prediction of therapy.
- Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumors.
- Evaluation of gene expression profiles of immature dendritic cells prepared from peripheral blood mononuclear cells.
- Helper B cells promote cytotoxic T cell survival and proliferation independently of antigen presentation through CD27/CD70 interactions.
- Conservation of genetic alterations in recurrent melanoma supports the melanoma stem cell hypothesis.
- The requirements for CTL-mediated rejection of cancer in humans: NKG2D and its role in the immune responsiveness of melanoma.
- Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus.
- Comparative analysis of peritoneum and tumor eicosanoids and pathways in advanced ovarian cancer.
- Tumor microenvironment and the immune response.
- Availability of a diversely avid CD8+ T cell repertoire specific for the subdominant HLA-A2-restricted HIV-1 Gag p2419-27 epitope.
- Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2'-deoxycytidine in cutaneous melanoma: immunotherapeutic implications.
- Widespread and ample peptide overlapping between HCV and Homo sapiens proteomes.
- Shared MHC class II-dependent melanoma ribosomal protein L8 identified by phage display.
- Gene profiling for the prediction of tumor response to treatment: the case of immunotherapy.
- Complementary techniques: RNA amplification for gene profiling analysis.
- Gene expression signatures of interleukin-2 in vivo and in vitro and their relation to anticancer therapy.
- Effects of storage time and exogenous protease inhibitors on plasma protein levels.
- Clonal persistence and evolution during a decade of recurrent melanoma.
- Human leukocyte antigen-A2-restricted CTL responses to mutated BRAF peptides in melanoma patients.
- Common cancer biomarkers.
- Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes.
- Autologous tumor rejection in humans: trimming the myths.
- Infectious pathogen detection arrays: viral detection in cell lines and postmortem brain tissue.
- Interleukin-10 and the immune response against cancer: a counterpoint.
- Cancer vaccines: pessimism in check.
- Immune responses of breast cancer patients to mutated epidermal growth factor receptor (EGF-RvIII, Delta EGF-R, and de2-7 EGF-R).
- Ontogeny and oncogenesis balance the transcriptional profile of renal cell cancer.
- Quiescent phenotype of tumor-specific CD8+ T cells following immunization.
- Overview of melanoma vaccines and promising approaches.
- DNA array-based gene profiling in tumor immunology.
- Synopsis of the 6th Walker's Cay Colloquium on Cancer Vaccines and Immunotherapy.
- Forecasting the cytokine storm following systemic interleukin (IL)-2 administration.
- Lost in Translation: Obstacles to Translational Medicine.
- Cytokine and chemokine expression profiles of maturing dendritic cells using multiprotein platform arrays.
- Cytokine polymorphism and its possible impact on cancer.
- Introduction of article-processing charges (APCs) for articles accepted for publication in the Journal of Translational Medicine.
- Active-specific immunization against melanoma: is the problem at the receiving end?
- Immunotherapy of melanoma: the good news, the bad ones and what to do next.
- Pyrosequencing trade mark : A one-step method for high resolution HLA typing.
- The matrix protein pp65(341-350): a peptide that induces ex vivo stimulation and in vitro expansion of CMV-specific CD8+ T cells in subjects bearing either HLA-A*2402 ...
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- Fellow (FACS)
Education
-
Stanford University -
University of Milan Faculty of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Louis A. Ivey II, MD |
|
|
Dr. Bruce K. Weathers, MD |
|
|
Dr. Kristen D. Trinca, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John W. Denobile, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Degon, MD |
|
|
Dr. Simon Turcotte, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kimberly Lindsey, MD |
|
|
Dr. David B. Wilde, MD |
|
|
Dr. Shane Ottmann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Juvenal R. Goicochea, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bonnie Sun, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeremiah Stubbs, MD
This Doctor is OpenDoctor Recommended.
|